Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background: Calcific Aortic Valve Disease (CAVD) is a prevalent heart valve disease. The ratio of two apolipoproteins with distinct functions (APOB/APOA1) has been proposed as a novel assessment index for the evaluation of cardiovascular diseases. The aim of this article is to discuss the role of lipids parameters such as APOB/APOA1 in CAVD and the risk factors for CAVD, to develop a predictive model for CAVD, and to evaluate the sensitivity and specificity of this model. Method: Patients who initially presented to the Department of Cardiology of the Second Affiliated Hospital of Dalian Medical University between 1 January 2023 and 31 December 2023 were retrospectively identified and included in the study. Patients were divided into an aortic valve calcification group (111 cases) and a control group (201 cases) based on CT findings. The patients' clinical data, laboratory examination results, and chest CT images were collected and analyzed. A variety of statistical methods were used to analyses risk factors for CAVD in order to construct a CAVD prediction model and to assess its sensitivity and specificity. Results:Lipid parameters APOA1, APOB/APOA1, cumulative LDL exposure and non-HDL/HDL were significantly associated with aortic valve calcification. Age, history of diabetes, DBP, APOB/APOA1, Cys-c and NLR are identified as independent risk factors for CAVD, and the combination of the above indexes in the prediction of aortic valve calcification was 0.796, corresponding to a sensitivity of 0.769 and a specificity of 0.755. Conclusion: APOA1, APOB/APOA1, cumulative LDL exposure, and Non-HDL/HDL have been demonstrated to be associated withCAVD. Furthermore, age, history of diabetes mellitus, DBP, APOB/APOA1, Cys-c, and NLR have been identified as valid predictors of CAVD.
Background: Calcific Aortic Valve Disease (CAVD) is a prevalent heart valve disease. The ratio of two apolipoproteins with distinct functions (APOB/APOA1) has been proposed as a novel assessment index for the evaluation of cardiovascular diseases. The aim of this article is to discuss the role of lipids parameters such as APOB/APOA1 in CAVD and the risk factors for CAVD, to develop a predictive model for CAVD, and to evaluate the sensitivity and specificity of this model. Method: Patients who initially presented to the Department of Cardiology of the Second Affiliated Hospital of Dalian Medical University between 1 January 2023 and 31 December 2023 were retrospectively identified and included in the study. Patients were divided into an aortic valve calcification group (111 cases) and a control group (201 cases) based on CT findings. The patients' clinical data, laboratory examination results, and chest CT images were collected and analyzed. A variety of statistical methods were used to analyses risk factors for CAVD in order to construct a CAVD prediction model and to assess its sensitivity and specificity. Results:Lipid parameters APOA1, APOB/APOA1, cumulative LDL exposure and non-HDL/HDL were significantly associated with aortic valve calcification. Age, history of diabetes, DBP, APOB/APOA1, Cys-c and NLR are identified as independent risk factors for CAVD, and the combination of the above indexes in the prediction of aortic valve calcification was 0.796, corresponding to a sensitivity of 0.769 and a specificity of 0.755. Conclusion: APOA1, APOB/APOA1, cumulative LDL exposure, and Non-HDL/HDL have been demonstrated to be associated withCAVD. Furthermore, age, history of diabetes mellitus, DBP, APOB/APOA1, Cys-c, and NLR have been identified as valid predictors of CAVD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.